Biocon Limited (NSE:BIOCON)

Biocon Statistics

Total Valuation

Biocon has a market cap or net worth of INR 564.16 billion. The enterprise value is 731.00 billion.

Market Cap	564.16B
Enterprise Value	731.00B

Important Dates

The next confirmed earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	Jul 4, 2025

Share Statistics

Biocon has 1.62 billion shares outstanding. The number of shares has increased by 5.94% in one year.

Current Share Class	1.62B
Shares Outstanding	1.62B
Shares Change (YoY)	+5.94%
Shares Change (QoQ)	+3.89%
Owned by Insiders (%)	46.00%
Owned by Institutions (%)	23.59%
Float	708.71M

Valuation Ratios

The trailing PE ratio is 73.23 and the forward PE ratio is 61.97. Biocon's PEG ratio is 1.07.

PE Ratio	73.23
Forward PE	61.97
PS Ratio	3.35
PB Ratio	1.71
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.07

Enterprise Valuation

EV / Earnings	120.99
EV / Sales	4.34
EV / EBITDA	21.45
EV / EBIT	43.07
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.50
Debt / EBITDA	4.85
Debt / FCF	n/a
Interest Coverage	1.77

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	3.58%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.57%
Revenue Per Employee	10.25M
Profits Per Employee	367,966
Employee Count	16,420
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Biocon has paid 576.00 million in taxes.

Income Tax	576.00M
Effective Tax Rate	8.38%

Stock Price Statistics

The stock price has increased by +13.75% in the last 52 weeks. The beta is 0.25, so Biocon's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	+13.75%
50-Day Moving Average	374.87
200-Day Moving Average	374.52
Relative Strength Index (RSI)	39.36
Average Volume (20 Days)	4,362,496

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biocon had revenue of INR 168.27 billion and earned 6.04 billion in profits. Earnings per share was 4.76.

Revenue	168.27B
Gross Profit	102.43B
Operating Income	16.97B
Pretax Income	6.87B
Net Income	6.04B
EBITDA	33.48B
EBIT	16.97B
Earnings Per Share (EPS)	4.76

Balance Sheet

The company has 61.04 billion in cash and 165.36 billion in debt, with a net cash position of -104.32 billion or -64.46 per share.

Cash & Cash Equivalents	61.04B
Total Debt	165.36B
Net Cash	-104.32B
Net Cash Per Share	-64.46
Equity (Book Value)	330.55B
Book Value Per Share	207.92
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	16.51B
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 60.87%, with operating and profit margins of 10.09% and 3.59%.

Gross Margin	60.87%
Operating Margin	10.09%
Pretax Margin	4.08%
Profit Margin	3.59%
EBITDA Margin	19.90%
EBIT Margin	10.09%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.14%.

Dividend Per Share	0.50
Dividend Yield	0.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.94%
Shareholder Yield	-5.80%
Earnings Yield	1.07%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jun 12, 2019
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	1